{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-257733","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2026-06-04T21:09:05+00:00","discovered_at":"2026-06-04T21:10:00.268315+00:00","generated_at":"2026-06-04T21:20:14.234967+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Jade Biosciences prices $150M public offering of 10M shares at $15/share","bullets":["Priced public offering of 10,000,000 shares of common stock at $15.00 per share for gross proceeds of $150.0M.","Net proceeds expected ~$140.3M (~$161.5M if underwriters’ 30-day option for 1.5M additional shares is exercised).","Intends use net proceeds for clinical trials, preclinical studies, manufacturing, R&D, capex, working capital, and general corporate purposes.","Jefferies, TD Cowen, UBS Investment Bank acting as joint book-running managers; offering expected to close June 5, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-257733","json":"https://secwatch.observer/filing/0001193125-26-257733.json","markdown":"https://secwatch.observer/filing/0001193125-26-257733.md","text":"https://secwatch.observer/filing/0001193125-26-257733.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526257733/0001193125-26-257733-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000119312526257733/d103726d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T21:20:14.234967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}